MAOA and non-small cell lung carcinoma: The authors expanded on this by performing cell culture experiments and demonstrated that AMPK activators mitigate NSCLC and colon cancer cell lines’ proliferation and migration via suppression of p38 mitogen-activated protein kinases (p38MAPK) activity with downregulation of MAO-A expression and activity [102].